One of the biggest moments at the annual meeting of the American Society of Clinical Oncology last month came when a drug investigator from M.D. Anderson Cancer Center presented explained that a recent clinical trial for the drug Avastin had left doctors "with no more clarity" about how to treat brain cancer patients than they had before the trial, according to the New York Times.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Magdalena Skipper, the incoming editor-in-chief of Nature, speaks with NPR's Weekend Edition Sunday.

Genetic genealogy has led to an arrest in another cold case, dating back to 1987.

In PLOS this week: mutation in second gene widens clinical symptoms of people with ADD3 mutations, comparative genomic analysis of Pseudovibrio, and more.

Wired reports that 23andMe is trying to bolster its outside collaborations.